Group One Trading
CPRX

Group One Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Group One Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,108
Closed -$174K – 7367
2024
Q3 		$161K Sell
8,108
-7,559
-48% -$140K ﹤0.01% 3811
2024
Q2 		$243K Buy
15,667
+4,657
+42% +$72.5K ﹤0.01% 3240
2024
Q1 		$175K Buy
+11,010
New +$166K ﹤0.01% 3674
2022
Q2 		– Sell
-9,242
Closed -$67.8K – 7909
2022
Q1 		$77K Buy
9,242
+3,689
+66% +$26.1K ﹤0.01% 5745
2021
Q4 		$38K Sell
5,553
-21,503
-79% -$141K ﹤0.01% 6526
2021
Q3 		$143K Sell
27,056
-78,192
-74% -$428K ﹤0.01% 5524
2021
Q2 		$605K Buy
+105,248
New +$543K ﹤0.01% 4007
2020
Q2 		– Sell
-201,698
Closed -$906K – 5829
2020
Q1 		$777K Buy
201,698
+37,795
+23% +$155K 0.01% 1723
2019
Q4 		$615K Sell
163,903
-22,895
-12% -$107K ﹤0.01% 2267
2019
Q3 		$992K Buy
186,798
+149,586
+402% +$797K 0.01% 1745
2019
Q2 		$143K Buy
+37,212
New +$161K ﹤0.01% 3086
2019
Q1 		– Sell
-16,764
Closed -$49.3K – 4878
2018
Q4 		$32K Buy
16,764
+2,458
+17% +$7.04K ﹤0.01% 3773
2018
Q3 		$54K Buy
14,306
+2,082
+17% +$6.52K ﹤0.01% 3930
2018
Q2 		$38K Buy
12,224
+10,239
+516% +$31.1K ﹤0.01% 4089
2018
Q1 		$5K Buy
1,985
+411
+26% +$1.37K ﹤0.01% 4496
2017
Q4 		$6K Sell
1,574
-979
-38% -$3.23K ﹤0.01% 4507
2017
Q3 		$6K Buy
+2,553
New +$7K ﹤0.01% 4425
2015
Q4 		– Sell
-1,398
Closed -$4K – 4784
2015
Q3 		$4K Buy
+1,398
New +$6.03K ﹤0.01% 4539
2014
Q3 		– Sell
-26,248
Closed -$68.6K – 5167
2014
Q2 		$66K Buy
26,248
+13,572
+107% +$29K ﹤0.01% 3345
2014
Q1 		$29K Sell
12,676
-224
-2% -$468 ﹤0.01% 3999
2013
Q4 		$25K Buy
+12,900
New +$26.1K ﹤0.01% 4120

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's CPRX Position: Q4 2024 in Review

Group One Trading sold out of Catalyst Pharmaceutical (CPRX) in Q4 2024, closing a stake of 8,108 shares — an estimated $174K sold.

Group One Trading first reported a position in CPRX in Q4 2013 and held it in 21 quarters. The position peaked at $992K in Q3 2019. 336 funds tracked by Wall St. Rank hold CPRX as of Q4 2024.

  • Group One Trading reported no remaining Catalyst Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 8,108 Catalyst Pharmaceutical shares in Q4 2024, an estimated $174K.
  • Group One Trading first reported a position in Catalyst Pharmaceutical in Q4 2013 and held it in 21 quarters.
  • Group One Trading's Catalyst Pharmaceutical position peaked at $992K in Q3 2019.
  • 336 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.